MCD(MCD)
MCD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $28.47B | $30.11B | $31.62B | $32.67B | $33.84B |
| Low | $27.94B | $29.36B | $31.58B | $31.74B | $32.88B |
| High | $28.74B | $30.80B | $31.66B | $33.39B | $34.59B |
| EBITDA Avg | $14.92B | $15.79B | $16.58B | $17.13B | $17.74B |
| Low | $14.64B | $15.39B | $16.55B | $16.64B | $17.24B |
| High | $15.06B | $16.15B | $16.60B | $17.50B | $18.13B |
| EBIT Avg | $12.65B | $13.38B | $14.05B | $14.51B | $15.03B |
| Low | $12.41B | $13.04B | $14.03B | $14.10B | $14.61B |
| High | $12.77B | $13.68B | $14.06B | $14.83B | $15.37B |
| Net Income Avg | $9.15B | $10.14B | $10.39B | $11.87B | $12.44B |
| Low | $9.06B | $9.97B | $10.34B | $11.43B | $11.98B |
| High | $9.40B | $10.30B | $11.38B | $12.21B | $12.79B |
| EPS Avg | $12.99 | $14.19 | $15.28 | $16.57 | $17.36 |
| Low | $12.65 | $13.92 | $14.44 | $15.96 | $16.72 |
| High | $13.12 | $14.38 | $15.89 | $17.05 | $17.86 |
| Analysts (Rev / EPS) | 23 / 19 | 24 / 21 | 14 / 8 | 9 / 6 | 13 / 6 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $7.15B | $7.44B | $7.40B | $6.88B | $7.58B | $7.87B | $7.83B | $7.29B |
| Low | $6.95B | $7.26B | $7.20B | $6.69B | $7.38B | $7.65B | $7.62B | $7.09B |
| High | $7.30B | $7.57B | $7.58B | $7.04B | $7.77B | $8.06B | $8.02B | $7.47B |
| EBITDA Avg | $3.75B | $3.90B | $3.88B | $3.60B | $3.98B | $4.13B | $4.11B | $3.82B |
| Low | $3.64B | $3.80B | $3.77B | $3.51B | $3.87B | $4.01B | $3.99B | $3.72B |
| High | $3.82B | $3.97B | $3.97B | $3.69B | $4.07B | $4.22B | $4.21B | $3.91B |
| EBIT Avg | $3.17B | $3.30B | $3.29B | $3.05B | $3.37B | $3.50B | $3.48B | $3.24B |
| Low | $3.09B | $3.22B | $3.20B | $2.97B | $3.28B | $3.40B | $3.38B | $3.15B |
| High | $3.24B | $3.36B | $3.37B | $3.13B | $3.45B | $3.58B | $3.56B | $3.32B |
| Net Income Avg | $2.39B | $2.47B | $2.40B | $2.19B | $2.58B | $2.70B | $2.64B | $2.37B |
| Low | $2.35B | $2.42B | $2.32B | $2.11B | $2.48B | $2.61B | $2.54B | $2.29B |
| High | $2.44B | $2.53B | $2.48B | $2.26B | $2.66B | $2.79B | $2.72B | $2.44B |
| EPS Avg | $3.35 | $3.46 | $3.37 | $3.07 | $3.61 | $3.79 | $3.70 | $3.32 |
| Low | $3.30 | $3.39 | $3.24 | $2.96 | $3.48 | $3.65 | $3.57 | $3.20 |
| High | $3.43 | $3.54 | $3.47 | $3.16 | $3.72 | $3.91 | $3.81 | $3.43 |
| Analysts (Rev / EPS) | 16 / 19 | 16 / 19 | 15 / 10 | 11 / 9 | 8 / 8 | 8 / 8 | 15 / 16 | 10 / 16 |